abstract |
ThenThe invention relates to a method for the noninvasive diagnosis ofnDiabetes, an early stagenor a diabetes risk, wherein the content of at least onenAnalytes selectednfrom the group comprising amino acids,nGlycation products and / or metabolic compounds comprisingnketone bodiesnin biological tissue, especially the skin, and determined withnthe average value of healthy biological tissue, in particularnthe skin, a significant difference being diabetes,nan early stagenor indicates a diabetes risk. |